Home/Filings/4/0001250853-21-000035
4//SEC Filing

Bevers Denise 4

Accession 0001250853-21-000035

CIK 0001561743other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:55 PM ET

Size

15.1 KB

Accession

0001250853-21-000035

Insider Transaction Report

Form 4
Period: 2021-02-19
Bevers Denise
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2021-02-22$5.00/sh4,622$23,1100 total(indirect: By SD Scientific, Inc.)
  • Sale

    Common Stock

    2021-02-19$5.00/sh5$250 total(indirect: By SD Scientific, Inc.)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-19513,081 total(indirect: By SD Scientific, Inc.)
    Exercise: $0.32From: 2013-05-09Exp: 2023-05-09Common Stock (5 underlying)
  • Exercise/Conversion

    Common Stock

    2021-02-19$0.32/sh+5$25 total(indirect: By SD Scientific, Inc.)
  • Exercise/Conversion

    Common Stock

    2021-02-22$0.32/sh+4,622$1,4794,622 total(indirect: By SD Scientific, Inc.)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-224,6228,396 total(indirect: By SD Scientific, Inc.)
    Exercise: $0.32From: 2013-05-09Exp: 2023-05-09Common Stock (4,622 underlying)
Holdings
  • Common Stock

    143,835
Footnotes (2)
  • [F1]Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020.

Issuer

Kindred Biosciences, Inc.

CIK 0001561743

Entity typeother

Related Parties

1
  • filerCIK 0001593865

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:55 PM ET
Size
15.1 KB